KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to 3.0%.

  • Exact Sciences' EBITDA Margin rose 25600.0% to 3.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.45%, marking a year-over-year decrease of 235300.0%. This contributed to the annual value of 38.01% for FY2024, which is 294100.0% down from last year.
  • Per Exact Sciences' latest filing, its EBITDA Margin stood at 3.0% for Q3 2025, which was up 25600.0% from 0.26% recorded in Q2 2025.
  • Exact Sciences' 5-year EBITDA Margin high stood at 1.09% for Q3 2023, and its period low was 122.84% during Q4 2024.
  • In the last 5 years, Exact Sciences' EBITDA Margin had a median value of 16.74% in 2024 and averaged 26.93%.
  • In the last 5 years, Exact Sciences' EBITDA Margin skyrocketed by 422500bps in 2021 and then tumbled by -1123500bps in 2024.
  • Quarter analysis of 5 years shows Exact Sciences' EBITDA Margin stood at 46.74% in 2021, then surged by 54bps to 21.5% in 2022, then skyrocketed by 51bps to 10.49% in 2023, then crashed by -1071bps to 122.84% in 2024, then surged by 98bps to 3.0% in 2025.
  • Its EBITDA Margin was 3.0% in Q3 2025, compared to 0.26% in Q2 2025 and 13.58% in Q1 2025.